Journal profile · BIOCHEMICAL RESEARCH METHODS
Clinical Proteomics
ISSN 1542-6416 · eISSN 1559-0275 · BioMed Central · ENGLAND · Founded 2004
Clinical Proteomics: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.3; fully open access; APC about USD 2,490; median 135 days to acceptance (99 articles, last 24 months); 53 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Proteomics is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Proteomics Techniques and Applications, Glycosylation and Glycoproteins Research and Mass Spectrometry Techniques and Applications, together about 44.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Proteomics encompasses all aspects of translational proteomics. This includes quantitative and qualitative profiling of proteins and peptides that are present in clinical specimens like human tissues and body fluids. Special emphasis is placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. As an open access journal, Clinical Proteomics is committed to rapid scientific review and timely publication of submitted manuscripts. This is achieved by receiving, processing and publishing submissions online. As molecular medicine moves beyond genomics to proteomics, the goal becomes the characterization of the cellular circuitry and the understanding of the impact of disease and therapy on precision medicine. Clinical Proteomics provides a scholarly forum for novel scientific research in the field of translational proteomics. The journal is publishing manuscripts with significant scientific discoveries or observations related to human diseases, for example the discovery and analytical and preclinical validation of novel diagnostic or therapy related markers, the potential of protein profiles for the development of personalized medicine. This will include original research articles and reviews in proteomics and bioinformatics. Articles in the development and application of technologies, clinical studies, methodologies, and protocols are also welcome.
From the journal's Aims & Scope
Research area (LetPub): BIOCHEMICAL RESEARCH METHODS
Editor-in-chief Daniel W ChanPublisher website
Editorial board by country: 4 in mainland China (about 6%); most named United States 38, Canada 5, Mainland China 4, Australia 3, Switzerland 3 (65 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Proteomics Techniques and ApplicationsChemistry29.3%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology8%
- Mass Spectrometry Techniques and ApplicationsChemistry7.1%
- Advanced Biosensing Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology6.8%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology5.7%
- Clusterin in disease pathologyMedicine3.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine3.5%
- S100 Proteins and AnnexinsBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemical Research Methods | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.3LetPub ·
- Impact factor (publisher) 2025
- 4.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 4Publisher website ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 1.04LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 25LetPub ·
- h-index
- 59OpenAlex ·
- i10-index
- 422OpenAlex ·
- 2-year mean citedness
- 4.46OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Downloads per year (publisher) 2025
- 540,600Publisher website ·
Articles by year OpenAlex count · 785 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 60 | 25 |
| 2025 | 53 | 53 | 173 |
| 2024 | 69 | 69 | 614 |
| 2023 | 56 | 56 | 806 |
| 2022 | 51 | 51 | 706 |
| 2021 | 32 | 32 | 549 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
135 daysMedian, submission to acceptance · P25–P75 81 days – 181 days
- Acceptance to online
- median 25 days (99 articles)
- Submission to online
- median 168 days
- Sample
- 99 articles with submission and acceptance dates (121 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,490 / EUR 2,090 / GBP 1,790 | — | — | |
| LetPub | EUR 2,090 / USD 2,490 / GBP 1,790 | Yes | — | |
| Publisher website | GBP 1,950 / USD 2,690 / EUR 2,290 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted6
- correspondenceFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
- meeting reportFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
- methodologyFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
- protocolFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
- researchFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
- reviewFormatting guidelines for specific article types can be found below. Correspondence Meeting report Research Review Methodology ProtocolLength not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review
- Authorship
Manuscript must be submitted by an author, not a third party. Model summary
Please note that a manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Source ↗Publisher website ·- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required; deposit in public repositories where appropriate; 'Availability of data and materials' section required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Clinical Proteomics articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Authors may suggest potential peer reviewers in cover letter; institutional email addresses or ORCID/Scopus ID preferred. Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2004
- ISSN
- 1542-6416
- Electronic ISSN
- 1559-0275
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Clinical Proteomics
What CAS zone is Clinical Proteomics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Proteomics is in Zone 3 of Medicine, and in Zone 2 of the minor category Biochemical Research Methods. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Proteomics?
The latest impact factor listed by LetPub is 4.3; CiteScore 6, h-index 59.
How long does peer review take at Clinical Proteomics?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 135 days (interquartile range 81–181 days); authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical Proteomics based?
Of the 65 board members whose country the journal's board page names, 4 (about 6%) are in mainland China; the countries named most often are United States (38), Canada (5) and Mainland China (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Proteomics?
According to LetPub and DOAJ records, Clinical Proteomics is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Clinical Proteomics open access, and what is the APC?
Clinical Proteomics is a fully open-access journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .